Antibiotic Dosing and Duration for Corneal Abrasion
For a simple traumatic corneal abrasion, prescribe a topical fluoroquinolone antibiotic (such as ofloxacin 0.3%, ciprofloxacin 0.3%, or levofloxacin 1.5%) applied 4 times daily for 5-7 days, with treatment initiated within 24 hours of injury to prevent bacterial keratitis. 1
Antibiotic Selection and Rationale
The 2024 Bacterial Keratitis Preferred Practice Pattern from the American Academy of Ophthalmology strongly recommends broad-spectrum topical antibiotics for any corneal abrasion following trauma, as prophylactic treatment prevents both bacterial and fungal ulceration when started within 24 hours 1. This recommendation prioritizes preventing the devastating complication of infectious keratitis, which can lead to permanent vision loss.
FDA-Approved Options:
- Ciprofloxacin 0.3% - FDA approved for bacterial keratitis
- Ofloxacin 0.3% - FDA approved for bacterial keratitis
- Levofloxacin 1.5% - FDA approved for bacterial keratitis 1
These fluoroquinolones achieve high corneal tissue levels and provide excellent gram-positive and gram-negative coverage 1.
Dosing Regimen
For Simple, Non-Central Abrasions:
- Frequency: 4 times daily (standard practice pattern) 2
- Duration: 5-7 days or until complete epithelial healing
- Formulation: Eye drops are preferred over ointments for better corneal penetration 1
Important caveat: Ointments may be added at bedtime for additional comfort in less severe cases, but drops remain the primary therapy due to superior corneal penetration 1.
For Severe or Central Abrasions:
If the abrasion involves deep stromal involvement or is larger than 2mm with extensive suppuration, escalate to:
- Loading dose: Every 5-15 minutes initially
- Maintenance: Every hour around the clock 1
Critical Clinical Considerations
Contact Lens-Related Abrasions:
These patients are at higher risk for Pseudomonas infection and require:
- Mandatory topical antibiotic prophylaxis
- Never patch the eye - patching increases bacterial keratitis risk 1
- Consider more aggressive fluoroquinolone coverage given Pseudomonas risk
Resistance Patterns to Consider:
While fluoroquinolones remain first-line, be aware that:
- 42% of Staphylococcal isolates show methicillin resistance with concurrent fluoroquinolone resistance 1
- Fourth-generation fluoroquinolones (moxifloxacin, gatifloxacin) have better gram-positive coverage but are not FDA-approved for this indication 1
- If patient has recent fluoroquinolone use, hospitalization, or recent ocular surgery, consider fortified antibiotics 1
What NOT to Do
Avoid eye patching in contact lens wearers - this significantly increases bacterial keratitis risk 1
Do not prescribe topical anesthetics for outpatient pain control - recent evidence shows an 81% increased risk of ED readmission when topical anesthetics are prescribed (RR 1.81), with 6.7% vs 3.7% readmission rates 3. The risk of corneal melting and delayed healing outweighs any short-term pain benefit.
Do not use chronic prophylactic antibiotics beyond the healing period, as this promotes resistant organism growth 1
Adjunctive Pain Management
Instead of topical anesthetics:
- Cycloplegics (e.g., cyclopentolate) for ciliary spasm relief and pain reduction 1
- Oral NSAIDs or acetaminophen for systemic pain control
- Consider therapeutic bandage contact lens in selected cases (60% of ophthalmologists use this approach) 2, though avoid in contact lens-related injuries
Follow-Up Strategy
If you choose not to prescribe antibiotics (controversial but practiced by 43% of surveyed ophthalmologists), you must schedule close follow-up within 24-48 hours to monitor for infection 2. However, given the evidence that prophylactic antibiotics prevent ulceration when started within 24 hours 1, the safer approach is to prescribe antibiotics routinely.
Ophthalmology follow-up within 30 days reduces readmission risk (RR 0.82) and should be arranged for any patient with concerning features 3.